GALWAY, Ireland , Feb. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthc...


    
    
    
      
          
		  
          
            
            
            ,  /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2025 on Tuesday, February 18, 2025. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's third quarter of fiscal year 2025, which ended on Friday, January 24, 2025.
Medtronic will host a video webcast at 7:00 a.m. CST on February 18, 2025, to discuss results for its third quarter of full fiscal year 2025. The webcast can be accessed at https://investorrelations.medtronic.com.
Within 24 hours of the broadcast, a replay and transcript of the prepared remarks will be available by clicking on the Events link at https://investorrelations.medtronic.com.
Looking ahead, Medtronic plans to report its fourth quarter fiscal year 2025 results on Wednesday, May 21, 2025. For fiscal year 2026, Medtronic plans to report its first, second, third, and fourth quarter results on Tuesday, August 19, 2025, November 18, 2025, February 17, 2026, and Wednesday, May 20, 2026, respectively. For these events, confirmation and additional details will be provided closer to the specific event.
About MedtronicBold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people second, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE: MDT), visit www.Medtronic.com and follow Medtronic on LinkedIn.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

   
    
     
      Contacts: 
      
     
     
      
      
     
     
      Erika Winkels                   
      Ryan Weispfenning 
     
     
      Public Relations              
      Investor Relations 
     
     
      +1-763-526-8478            
      +1-763-505-4626 
     
    
   
  
SOURCE Medtronic plc

          
        
      
        
            WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

        
        
            
        
            
        
            
        
            
        
            
        
            
        
            
        
            
                
                    
                        
                        
                        
                            440k+
Newsrooms &
Influencers
                        
                    
                
                    
                        
                        
                        
                            9k+
Digital Media
Outlets
                        
                    
                
                    
                        
                        
                        
                            270k+
Journalists
Opted In
                        
                    
                
            
        
        
    
    

  

Medtronic to announce financial results for its third quarter of fiscal year 2025

Medtronic will report Q3 fiscal year 2025 results on February 18, 2025.
A webcast will discuss the financial results at 7:00 a.m. CST.
Q4 fiscal year 2025 results are planned for May 21, 2025.
Fiscal year 2026 results reporting schedule is outlined for all quarters.
Medtronic's diverse technologies address numerous health conditions globally.

Medtronic to announce financial results for its third quarter of fiscal year 2025

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Earnings

Related News